PRAX
Price
$268.98
Change
+$2.40 (+0.90%)
Updated
Jun 15, 12:31 PM (EDT)
Capitalization
7.43B
56 days until earnings call
Intraday BUY SELL Signals
RAPP
Price
$39.43
Change
+$1.03 (+2.68%)
Updated
Jun 15, 12:26 PM (EDT)
Capitalization
1.84B
52 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PRAX vs RAPP

Header iconPRAX vs RAPP Comparison
Open Charts PRAX vs RAPPBanner chart's image
PRAX vs RAPP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PRAX vs. RAPP commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRAX is a Hold and RAPP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2026
Stock price -- (PRAX: $266.58 vs. RAPP: $38.40)
Brand notoriety: PRAX and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRAX: 96% vs. RAPP: 76%
Market capitalization -- PRAX: $7.43B vs. RAPP: $1.84B
PRAX [@Biotechnology] is valued at $7.43B. RAPP’s [@Biotechnology] market capitalization is $1.84B. The market cap for tickers in the [@Biotechnology] industry ranges from $112.92B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRAX’s FA Score shows that 0 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • PRAX’s FA Score: 0 green, 5 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, RAPP is a better buy in the long-term than PRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRAX’s TA Score shows that 5 TA indicator(s) are bullish while RAPP’s TA Score has 3 bullish TA indicator(s).

  • PRAX’s TA Score: 5 bullish, 5 bearish.
  • RAPP’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PRAX is a better buy in the short-term than RAPP.

Price Growth

PRAX (@Biotechnology) experienced а +4.95% price change this week, while RAPP (@Biotechnology) price change was +6.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.18%. For the same industry, the average monthly price growth was +0.23%, and the average quarterly price growth was +2386.68%.

Reported Earning Dates

PRAX is expected to report earnings on Aug 10, 2026.

RAPP is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+3.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($7.43B) has a higher market cap than RAPP($1.84B). RAPP YTD gains are higher at: 26.566 vs. PRAX (-9.554). RAPP has higher annual earnings (EBITDA): -121.21M vs. PRAX (-357.2M). PRAX has more cash in the bank: 787M vs. RAPP (477M). PRAX has less debt than RAPP: PRAX (1.44M) vs RAPP (10.8M). RAPP has higher revenues than PRAX: RAPP (20M) vs PRAX (0).
PRAXRAPPPRAX / RAPP
Capitalization7.43B1.84B405%
EBITDA-357.2M-121.21M295%
Gain YTD-9.55426.566-36%
P/E RatioN/A21.81-
Revenue020M-
Total Cash787M477M165%
Total Debt1.44M10.8M13%
TECHNICAL ANALYSIS
Technical Analysis
PRAXRAPP
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 12 days ago
90%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 6 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 8 days ago
72%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PRAX
Daily Signal:
Gain/Loss:
RAPP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PSBD10.770.14
+1.32%
Palmer Square Capital BDC
IDA142.981.42
+1.00%
IDACORP
HAVAU10.24N/A
N/A
Harvard Ave Acquisition Corp.
SION35.92-0.13
-0.36%
Sionna Therapeutics Inc
STRR11.04-0.30
-2.60%
Star Equity Holdings Inc

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with ACRV. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then ACRV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
+9.06%
ACRV - RAPP
36%
Loosely correlated
+2.78%
PRAX - RAPP
35%
Loosely correlated
+7.50%
FTRE - RAPP
35%
Loosely correlated
-2.31%
MLTX - RAPP
34%
Loosely correlated
+5.30%
DNTH - RAPP
34%
Loosely correlated
+7.35%
More